Trial
NCT05160168
A Study of THE-630 in Patients With Advanced Gastrointestinal Stromal Tumors (GIST)
Phase ITERMINATEDSAFETYConfidence: HIGH
Sponsor
Theseus Pharmaceuticals
Collaborators
—
Condition
Gastrointestinal Stromal Tumors (GIST)
Intervention
THE-630
Why stopped
The Sponsor terminated the study due to early dose-limiting toxicities.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-06-05